ChemoMetec ASOCSE:CHEMM +0.38%99 Interest Coverage is 114.62 as of Dec. 2025, which is 13% above its 10-year median of 101.38. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 467 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 81.58% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. ChemoMetec AS's
Operating Income
for the
six
months ended in Dec. 2025 was kr120.6 Mil. ChemoMetec AS's Interest Expense for the
six
months ended in Dec. 2025 was kr-1.1 Mil.
ChemoMetec AS's interest coverage for the quarter that ended in Dec. 2025 was 114.62.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. ChemoMetec AS has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for ChemoMetec AS's Interest Coverage or its related term are showing as below:
OCSE:CHEMM'
s Interest Coverage Range Over the Past 10 Years
Min: 9.55 Med: 101.38 Max: 938.69
Current: 181.95
OCSE:CHEMM's Interest Coverage is ranked better than 81.58% of 467
companies
in the Medical Devices & Instruments industry
Industry Median: 15.72
vs OCSE:CHEMM: 181.95
ChemoMetec AS (OCSE:CHEMM) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
ChemoMetec AS Interest Coverage Related Terms
ChemoMetec AS Interest Coverage Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
OCSE:CHEMM vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, ChemoMetec AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Interest Coverage distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a Interest Coverage of 114.62 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on ChemoMetec AS and its competitors. This is 13% above median its historical median of 101.38. Over the past decade, ChemoMetec AS's Interest Coverage has ranged from 9.55 to 938.69. According to the industry distribution chart, ChemoMetec AS ranks #86 out of 467 companies in the Medical Devices & Instruments industry, placing it in the top 18.4%.
Is ChemoMetec AS's Interest Coverage too high?
ChemoMetec AS's current Interest Coverage of 114.62 is 13% above median its 10-year median of 101.38. Over the past 10 years, this metric has ranged from a low of 9.55 to a high of 938.69. The Medical Devices & Instruments industry median Interest Coverage is 15.72. ChemoMetec AS's value of 114.62 is 629.1% above this industry median. Based on the distribution chart, ChemoMetec AS ranks #86 out of 467 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #86 out of 467 companies for Interest Coverage. This places ChemoMetec AS in the top 18% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 15.72. ChemoMetec AS's value of 114.62 is 629.1% above this benchmark. Historically, ChemoMetec AS's own Interest Coverage has ranged from 9.55 to 938.69 over the past decade. While the company's 10-year median is 101.38 vs. the industry median of 15.72, ChemoMetec AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.72, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current Interest Coverage of 114.62 is 629.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Interest Coverage is 114.62, which is 13% above median its own 10-year median of 101.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr370.60 — trading 29.2% below its estimated fair value. The current Interest Coverage is 114.62, which is 13% above median its 10-year median of 101.38 and 629.1% above the Medical Devices & Instruments industry median of 15.72. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Interest Coverage is 114.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr370.60 is trading 29.2% below its estimated GF Value™ of kr523.33.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
Interest Coverage: 114.62 (13% above median its 10-year median of 101.38)
GF Value™: kr523.33 vs. price of kr370.60 (29.2% below fair value)
Industry Position: 629.1% above the Medical Devices & Instruments median (#86 of 467)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
